Summary
Although the cause of amyotrophic lateral sclerosis (ALS) remains unknown, biological findings suggest that the excitatory amino acid glutamate contributes to the pathogenesis of ALS. In previous studies of ALS, the therapeutic effect of the branched-chain amino acids (BCAAs) leucine, valine and isoleucine has been evaluated. The present study aimed at investigating the acute effect of BCAAs on plasma glutamate levels in ALS patients. Following two oral doses of BCAAs, significantly increased plasma levels were seen for valine (500%), isoleucine (1,377%) and leucine (927%), however the plasma level of glutamate was not affected. The plasma level of several other amino acids (tryptophan, tyrosine, phenylalanine and methionine) were found decreased after oral BCAAs, which may indicate a diminution in the rate of degradation of muscle protein and/or an increase in tissue disposal of amino acids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beghi E, Fiordelli E, Mora G, et al. (1993) Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? Neurology 43: 2466–2470
Blomstrand E, Newsholme EA (1992) Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle. Acta Physiol Scand 146: 293–298
Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634
Erecinska M, Nelson D (1990) Activation of glutamate dehydrogenase by leucine and its nonmetabolizable analogue in rat brain synaptosomes. J Neurochem 54: 1335–1343
Eriksson S, Hagenfeldt L, Wahren J (1981) A comparison of the effects of intravenous infusion of individual branched-chain amino acids on blood amino acid levels in man. Clin Sci 60: 95–100
Gredal O, Møller SE (1995) Effect of branched-chain amino acids on glutamate metabolism in amyotrophic lateral sclerosis. J Neurol Sci 129: 40–43
Hagenfeldt L, Eriksson S, Wahren J (1980) Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects. Clin Sci 59: 173–181
Hugon J, Tabaraud F, Rigaud M, Vallat JM, Dumas M (1989) Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease. Neurology 39: 956–958
Iwasaki Y, Ikeda K, Kinoshita M (1992) Plasma amino acid levels in patients with amyotrophic lateral sclerosis. J Neurol Sci 107: 219–222
Jimenez Jimenez FJ, Ortiz Leyba C, Morales Menedez S, Barros Perez M, Munoz Garcia J (1991) Prospective study on the efficacy of branched-chain amino acids in septic patients. JPEN J Parenter Enteral Nutr 15: 252–261
Jimenez Jimenez FJ, Ortiz Leyba C, Morales Mendez S, Barros Perez M, Munoz Garcia J, Herruzo Aviles A (1992) Variations in plasma amino acids in septic patients subjected to parenteral nutrition with a high proportion of branched-chain amino acids. Nutrition 8: 237–244
Louard RJ, Barrett EJ, Gelfand RA (1990) Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin Sci 79: 457–466
Malessa S, Leigh N, Hornykiewicz O (1988) Branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet ii: 680–682
Munsat TL, Hollander D (1990) Excitotoxins and amyotrophic lateral sclerosis. Therapie 45: 277–279
Møller SE (1993) Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography. J Chromatogr 613: 223–230
Perry TL, Krieger C, Hansen S, Eisen A (1990) Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol 28: 12–17
Plaitakis A, Caroscio JT (1987) Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22: 575–579
Plaitakis A, Smith J, Mandeli J, Yahr MD (1988) Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet i: 1015–1018
Plauth M, Egberts EH, Hamster W, et al. (1993) Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol 17: 308–314
Schwenk WF, Haymond MW (1987) Effects of leucine, isoleucine, or threonine infusion on leucine metabolism in humans. Am J Physiol 253: E428-E434
Testa D, Caraceni T, Fetoni V (1989) Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis. J Neurol 236: 445–447
Yielding KL, Tomkins GM (1961) An effect of L-leucine and other essential amino acids on the structure and activity of glutamic dehydrogenase. Proc Natl Acad Sci 47: 983–989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gredal, O., Møller, S.E. Effects of branched-chain amino acids on plasma amino acids in amyotrophic lateral sclerosis. Amino Acids 11, 37–42 (1996). https://doi.org/10.1007/BF00805719
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00805719